The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.17651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Mei Hong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Nanopores, Sepsis, Communicable Diseases, Hematologic Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Traditional microbiological methodology has limited sensitivity, detection range, and turnaround times in diagnosis of bloodstream infection in Febrile Neutropenia (FN) patients. A more rapid and sensitive detection technology is urgently needed. Here we used the newly developed Nanapore targeted sequencing (NTS) to diagnose the pathogens in blood samples. The diagnostic performance (sensitivity, specificity and turnaround time) of NTS detection of 202 blood samples from FN patients with hematologic disease was evaluated in comparison to blood culture and nested Polymerase Chain Reaction (PCR) followed by sanger sequence. The impact of NTS results on antibiotic treatment modification, the effectivity and mortality of the patients under the guidance of NTS results were assessed. The data showed that NTS had clinical sensitivity of 92.11%, clinical specificity of 78.41% compared with the blood culture and PCR combination. Importantly, the turnaround time for NTS was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Wuhan Dgensee Clinical Laboratory Co., Ltd., Wuhan, China.
ORCID-Profile: Danyue Peng
Zitieren
APA
Hong, M., Peng, D., Fu, A., Wang, X., Zheng, Y., Xia, L., Shi, W., Qian, C., Li, Z., Liu, F., & Wu, Q. (2023). The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17651
Vancouver
Hong M, Peng D, Fu A, Wang X, Zheng Y, Xia L, et al. The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17651
BibTeX
@article{Hong2023,
author = {Hong, Mei and Peng, Danyue and Fu, Aisi and Wang, Xian and Zheng, Yabiao and Xia, Linghui and Shi, Wei and Qian, Chenjing and Li, Zixuan and Liu, Fang and Wu, Qiuling},
title = {The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.17651}
}
EUVIMED